Iron in chronic brain disorders: imaging and neurotherapeutic implications (Q31117154)

11 August 2017

1 reference

title

Iron in chronic brain disorders: imaging and neurotherapeutic implications (English)

1 reference

11 August 2017

James Stankiewicz

1

1 reference

11 August 2017

S Scott Panter

2

1 reference

11 August 2017

Mohit Neema

3

1 reference

11 August 2017

Ashish Arora

4

1 reference

11 August 2017

Courtney E Batt

5

1 reference

11 August 2017

Rohit Bakshi

6

1 reference

11 August 2017

1 July 2007

1 reference

11 August 2017

1 reference

11 August 2017

4

1 reference

11 August 2017

3

1 reference

11 August 2017

371-386

1 reference

Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Advances in the treatment of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Echo-spacing optimization for the simultaneous measurement of reversible (R2') and irreversible (R2) transverse relaxation rates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Superficial siderosis: a case report and review of the literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Magnetic resonance imaging of iron deposition in neurological disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Potential sources of increased iron in the substantia nigra of parkinsonian patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron metabolism in Parkinsonian syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Magnetic field correlation imaging.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Imaging iron stores in the brain using magnetic resonance imaging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron, brain ageing and neurodegenerative disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Hereditary causes of disturbed iron homeostasis in the central nervous system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Oxidative stress and redox-active iron in Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron metabolism and the IRE/IRP regulatory system: an update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron and Parkinson's Disease: Chelators to the Rescue?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron misregulation in the brain: a primary cause of neurodegenerative disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Magnetic resonance imaging of brain iron

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

21 June 2018

Brain iron homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Redox-active iron mediates amyloid-beta toxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The physiopathological significance of ceruloplasmin. A possible therapeutic approach.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Glycochelates and the etiology of diabetic peripheral neuropathy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron deposits in multiple sclerosis and Alzheimer's disease brains.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Theory and application of static field inhomogeneity effects in gradient-echo imaging.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Use of desferrioxamine in the treatment of aceruloplasminemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

In vivo measurement of T2 distributions and water contents in normal human brain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Oxidative stress and the pathogenesis of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Hereditary caeruloplasmin deficiency: clinicopathological study of a patient

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Magnetic resonance imaging of corticobasal degeneration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Relationship of iron to oligodendrocytes and myelination

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The possible role of iron in the etiopathology of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The pathogenesis of superficial siderosis of the central nervous system.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

MR detection of brain iron

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Isoforms of ferritin have a specific cellular distribution in the brain.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Toluene abuse: physical basis for hypointensity of the basal ganglia on T2-weighted MR images

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Increased nigral iron content in postmortem parkinsonian brain.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

T2 values in the human brain: comparison with quantitative assays of iron and ferritin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Decreased ferritin levels in brain in Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Oxidative stress as a cause of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Intramuscular desferrioxamine in patients with Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron and oxygen radicals in brain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Novel inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Use of allopurinol and deferoxamine in cellular protection during ischemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Biological significance of iron-related magnetic resonance imaging changes in the brain

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

The free radical hypothesis in idiopathic parkinsonism: evidence against it

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyethyl starch-conjugated deferoxamine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Palatal tremor and cognitive decline in neuroferritinopathy

21 June 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

T(2) relaxation rate of basal ganglia and cortex in patients with beta-thalassaemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Correlation of R2 with total iron concentration in the brains of rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

T2 relaxation time in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Method for image-based measurement of the reversible and irreversible contribution to the transverse-relaxation rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Inhibition of iron-dependent and ischemia-induced brain damage by the alpha-tocopherol analogue MDL 74,722.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

A transient treatment of hippocampal neurons with alpha-tocopherol induces a long-lasting protection against oxidative damage via a genomic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

The effect of age on the non-haemin iron in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Transferrin C2, metal binding and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Nutritional iron deprivation attenuates kainate-induced neurotoxicity in rats: implications for involvement of iron in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

A non-essential function for yeast frataxin in iron-sulfur cluster assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Increased iron in the dentate nucleus of patients with Friedrich's ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

FLAIR MRI of striatonigral degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Deferoxamine improves spatial memory performance following experimental brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Dextran-coupled deferoxamine improves outcome in a murine model of head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Effects of an extracellular metal chelator on neurovascular function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Iron chelation improves endothelial function in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2007.05.006

Antioxidant responses of cortex neurons to iron loading.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

MR imaging of cerebral cortical involvement in aceruloplasminemia.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Oxidative stress, mitochondrial respiration, and Parkinson's disease.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Iron deposits surrounding multiple sclerosis plaques.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

Brain trace elements in Alzheimer's disease.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1963417

MR evaluation of age-related increase of brain iron in young adult and older normal males

25 November 2018

1 reference

12 December 2020

Determination of transverse relaxation rate for estimating iron deposits in central nervous system

1 reference

12 December 2020

An MRI method for measuring T2 in the presence of static and RF magnetic field inhomogeneities

1 reference

12 December 2020

Ceruloplasmin in neurodegenerative diseases

1 reference

12 December 2020

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

1 reference

12 December 2020

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1 reference

12 December 2020

High-dose tirilazad for acute stroke (RANTTAS II). RANTTAS II Investigators

1 reference

12 December 2020

Oral administration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis

1 reference

12 December 2020

A multiple course trial of desferrioxamine in chronic progressive multiple sclerosis

1 reference

12 December 2020

Iron in parkinsonian and control substantia nigra--a Mössbauer spectroscopy study

1 reference

12 December 2020

The relation between brain iron and NMR relaxation times: an in vitro study

1 reference

12 December 2020

MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation

1 reference

12 December 2020

Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats

1 reference

12 December 2020

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

12 December 2020

T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores

1 reference

12 December 2020

Imaging of brain iron by magnetic resonance: T2 relaxation at different field strengths

1 reference

12 December 2020

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study

1 reference

12 December 2020

T2rho-weighted contrast in MR images of the human brain

1 reference

12 December 2020

The basal ganglia in haemochromatosis

1 reference

12 December 2020

Suppression of hyperacute and passively transferred experimental autoimmune encephalomyelitis by the anti-oxidant, butylated hydroxyanisole

1 reference

12 December 2020

Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites

1 reference

12 December 2020

A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators

1 reference

12 December 2020

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

12 December 2020

10.1016/J.NURT.2007.05.006

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference